Search research articles
Contact Us
Filters
Showing results (131-140 of 146) with videos related to
Page
of 15
Sort By:
The New England Journal of Medicine
|
August 9, 1990
Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus
A S Kennington, C R Hill, J Craig, et al.
The Journal of Laboratory and Clinical Medicine
|
November 24, 1999
Time course of lipopolysaccharide-induced nitric oxide synthase mRNA expression in rat glomeruli
K Sade, D Schwartz, Y Wolman, et al.
International Journal of Clinical Practice
|
September 29, 2009
Practical guidance on intensification of insulin therapy with BIAsp 30: a consensus statement
A G Unnikrishnan, J Tibaldi, M Hadley-Brown, et al.
Kidney International
|
August 1, 2000
Renal nitric oxide production during the early phase of experimental diabetes mellitus
S Keynan, B Hirshberg, N Levin-Iaina, et al.
Diabetologia
|
July 6, 2004
Antidiabetic effect of novel modulating peptides of G-protein-coupled kinase in experimental models of diabetes
Y Anis, O Leshem, H Reuveni, et al.
International Journal of Dermatology
|
September 16, 1999
Maggot therapy for the treatment of intractable wounds
K Y Mumcuoglu, A Ingber, L Gilead, et al.
Diabetes Care
|
November 5, 1998
Maggot therapy for the treatment of diabetic foot ulcers
K Y Mumcuoglu, A Ingber, L Gilead, et al.
The New England Journal of Medicine
|
September 22, 2001
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
E J Lewis, L G Hunsicker, W R Clarke, et al.
The American Journal of Physiology
|
November 1, 1990
Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ
F Zurlo, S Lillioja, A Esposito-Del Puente, et al.
Clinical Pharmacology and Therapeutics
|
September 27, 2013
The importance of short-term off-target effects in estimating the long-term renal and cardiovascular protection of angiotensin receptor blockers
P A Smink, Y Miao, M J C Eijkemans, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 146) with videos related to
Sort By:
Page
of 15
The New England Journal of Medicine
|
August 9, 1990
Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus
A S Kennington, C R Hill, J Craig, et al.
The Journal of Laboratory and Clinical Medicine
|
November 24, 1999
Time course of lipopolysaccharide-induced nitric oxide synthase mRNA expression in rat glomeruli
K Sade, D Schwartz, Y Wolman, et al.
International Journal of Clinical Practice
|
September 29, 2009
Practical guidance on intensification of insulin therapy with BIAsp 30: a consensus statement
A G Unnikrishnan, J Tibaldi, M Hadley-Brown, et al.
Kidney International
|
August 1, 2000
Renal nitric oxide production during the early phase of experimental diabetes mellitus
S Keynan, B Hirshberg, N Levin-Iaina, et al.
Diabetologia
|
July 6, 2004
Antidiabetic effect of novel modulating peptides of G-protein-coupled kinase in experimental models of diabetes
Y Anis, O Leshem, H Reuveni, et al.
International Journal of Dermatology
|
September 16, 1999
Maggot therapy for the treatment of intractable wounds
K Y Mumcuoglu, A Ingber, L Gilead, et al.
Diabetes Care
|
November 5, 1998
Maggot therapy for the treatment of diabetic foot ulcers
K Y Mumcuoglu, A Ingber, L Gilead, et al.
The New England Journal of Medicine
|
September 22, 2001
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
E J Lewis, L G Hunsicker, W R Clarke, et al.
The American Journal of Physiology
|
November 1, 1990
Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ
F Zurlo, S Lillioja, A Esposito-Del Puente, et al.
Clinical Pharmacology and Therapeutics
|
September 27, 2013
The importance of short-term off-target effects in estimating the long-term renal and cardiovascular protection of angiotensin receptor blockers
P A Smink, Y Miao, M J C Eijkemans, et al.
Page
of 15